Skip to main content

Quadrature Capital Ltd

Source: SEC Form 13F · as of Mar 2026

Quadrature Capital Ltd holds 86 biotech & pharma companies tracked by BioSniper, totaling $91.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

86

Total value held

$91.1M

BioSniper AIPage evidence connected

Prepared research question

What matters most for ALNYLAM PHARMACEUTICALS, INC. (ALNY)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
ALNYALNYLAM PHARMACEUTICALS, INC.85,241$28.2M
REGNREGENERON PHARMACEUTICALS, INC.18,602$14.4M
GILDGILEAD SCIENCES, INC.56,928$7.9M
EXELEXELIXIS, INC.90,140$3.9M
ARWRARROWHEAD PHARMACEUTICALS, INC.55,546$3.5M
SNYSanofi60,025$2.9M
AVTXAvalo Therapeutics, Inc.125,195$1.9M
ADMAADMA BIOLOGICS, INC.204,475$1.8M
RVMDREVOLUTION MEDICINES, INC.16,667$1.6M
JAZZJazz Pharmaceuticals plc7,796$1.5M
VKTXViking Therapeutics, Inc.40,131$1.3M
PVLAPALVELLA THERAPEUTICS, INC.8,232$1.0M
NTLAIntellia Therapeutics, Inc.75,032$962K
TVTXTravere Therapeutics, Inc.31,729$943K
GMABGenmab A/S33,399$896K
XOMAXOMA Royalty Corporation28,495$894K
CLDXCelldex Therapeutics, Inc.24,440$775K
KALVKalVista Pharmaceuticals, Inc.35,123$707K
PGENPRECIGEN, INC.179,359$694K
RCUSArcus Biosciences, Inc.32,108$694K
OCSOculis Holding AG25,482$678K
TGTXTG THERAPEUTICS, INC.18,877$627K
SUPNSUPERNUS PHARMACEUTICALS, INC.11,501$594K
IMCRImmunocore Holdings plc19,254$581K
IOVAIOVANCE BIOTHERAPEUTICS, INC.158,929$558K
ARQTArcutis Biotherapeutics, Inc.23,157$546K
BMRNBIOMARIN PHARMACEUTICAL INC9,492$536K
FBRXForte Biosciences, Inc.18,622$482K
IVAInventiva S.A.84,323$468K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)8,425$465K
ZYMEZymeworks Inc.16,735$419K
PHVSPharvaris N.V.13,723$388K
ASRTAssertio Holdings, Inc.18,687$356K
GERNGERON CORP232,332$346K
STOKStoke Therapeutics, Inc.10,293$335K
FLGTFulgent Genetics Inc.19,640$312K
GRCEGrace Therapeutics, Inc.66,822$309K
FDMT4D Molecular Therapeutics, Inc.32,524$303K
KODKodiak Sciences Inc.7,868$300K
MESOMesoblast Limited17,247$265K
OVIDOvid Therapeutics Inc.111,804$248K
TENXTENAX THERAPEUTICS, INC.15,472$247K
LBRXLB PHARMACEUTICALS INC9,931$245K
CAPRCAPRICOR THERAPEUTICS, INC.7,900$240K
TNXPTonix Pharmaceuticals Holding Corp.17,410$239K
KRROKorro Bio, Inc.20,356$230K
TRDAEntrada Therapeutics, Inc.17,538$221K
CRBPCorbus Pharmaceuticals Holdings, Inc.22,986$216K
RLAYRelay Therapeutics, Inc.21,123$210K
AVXLANAVEX LIFE SCIENCES CORP.60,336$185K
ELTXElicio Therapeutics, Inc.16,912$181K
MISTMilestone Pharmaceuticals Inc.149,105$177K
LXRXLEXICON PHARMACEUTICALS, INC.110,379$172K
ADPTAdaptive Biotechnologies Corp12,387$172K
CCCCC4 Therapeutics, Inc.62,760$165K
CGEMCullinan Therapeutics, Inc.10,577$150K
DMACDiaMedica Therapeutics Inc.22,039$149K
FATEFATE THERAPEUTICS INC120,343$144K
SABSSAB BIOTHERAPEUTICS, INC.35,264$135K
ABCLAbCellera Biologics Inc.37,972$133K
BBOTBridgeBio Oncology Therapeutics, Inc.13,351$119K
SVRASavara Inc21,344$117K
PBYIPUMA BIOTECHNOLOGY, INC.16,745$107K
CADLCandel Therapeutics, Inc.21,023$103K
IVVDInvivyd, Inc.78,433$102K
OPKOPKO HEALTH, INC.88,937$101K
KURAKura Oncology, Inc.12,227$99K
CMPSCOMPASS Pathways plc17,891$99K
SPROSpero Therapeutics, Inc.40,128$94K
ANNXAnnexon, Inc.16,903$94K
RLMDRELMADA THERAPEUTICS, INC.12,498$87K
ALGSAligos Therapeutics, Inc.10,822$80K
BDTXBlack Diamond Therapeutics, Inc.37,474$80K
ZNTLZentalis Pharmaceuticals, Inc.33,332$78K
AUTLAutolus Therapeutics plc54,733$76K
CMPXCompass Therapeutics, Inc.13,845$73K
BMEABiomea Fusion, Inc.46,162$71K
PLRXPLIANT THERAPEUTICS, INC.50,981$64K
ALVOAlvotech16,412$56K
ADAGAdagene Inc.11,617$46K
ALECAlector, Inc.19,486$42K
SANASana Biotechnology, Inc.14,004$40K
IMUXIMMUNIC, INC.29,627$33K
CHRSCoherus Oncology, Inc.17,775$30K
PRQRProQR Therapeutics N.V.12,035$19K
IMMPImmutep Limited26,910$9K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.